platinum-based chemotherapy

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer Bookmark

Research paper from The New England Journal of Medicine curated by Editor in Chief George Lundberg, MD, who notes: 

These clinical trials results suggest that the drug niraparib is superior to platinum-based chemotherapy for people with newly diagnosed advanced ovarian cancer.

Go to full paper published in The New England Journal of Medicine.

If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.